Our results provide new insight into the regulatory mechanism of RANKL/RANK pathway-mediated breast cancer cell migration, and suggest that combined analysis of Cbl-b and RANK as biomarkers could be useful for the characterization of breast cancer patients. The gene discussed is CBLB; the disease is breast carcinoma.